ReviewCureus2025
Global Variability in the Management of Inflammatory Bowel Disease: Towards Context-Specific Strategies.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic, relapsing conditions with increasing prevalence worldwide, thought to be driven by socioeconomic and environmental factors. Managing IBD effectively across diverse healthcare settings remains a significant challenge, as there is no universal approach. Advances such as biologic therapies, biosimilars, and small molecule agents have improved outcomes; however, disparities in access, infrastructure, and costs persist, especially in resource-limited regions. As the therapeutic landscape expands, regional treatment hierarchies are increasingly shaped by resource availability, economic constraints, and healthcare system capacity. This narrative review synthesises current evidence and explores how resource availability influences treatment decision-making. It further discusses the potential of early diagnosis, preventive strategies, and dietary interventions to enhance patient outcomes and advance cost-effective care globally. Emphasising the importance of adaptable, patient-centred management, this narrative review aims to inform healthcare providers and policymakers on tailoring IBD care to maximise disease control and healthcare efficiency across diverse resource settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.